Glucocorticoid receptor and treatment of psychotic major depression.
Hui
Xin
X
The National Center for Drug Screening, Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 201203, China.
Zhou
Cai-hong
CH
Wang
Ming-wei
MW
D000818:Animals; D001921:Brain / Q000378:metabolism; D003687:Dehydroepiandrosterone / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D008797:Metyrapone / Q000627:therapeutic use; D015735:Mifepristone / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D011743:Pyrimidines / Q000627:therapeutic use; D018019:Receptors, Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors; D011965:Receptors, Glucocorticoid / Q000037:antagonists & inhibitors / Q000378:metabolism*
D011743:Pyrimidines; C412383:R 121919; D018019:Receptors, Corticotropin-Releasing Hormone; D011965:Receptors, Glucocorticoid; D015735:Mifepristone; D003687:Dehydroepiandrosterone; D008797:Metyrapone